Other News

Vascular Graft Solutions Wins FDA approval to Market the VIOLA™ Clampless Proximal Anastomosis System for CABG

TEL AVIV, Israel, March 1, 2021 /PRNewswire/ — Vascular Grafts Solutions (VGS) Ltd. announced today receipt of marketing clearance from the Food and Drug Administration (FDA) for the VIOLA™, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG) Neurocognitive dysfunction remains the most devastating perioperative complication of CABG […]

Axon Therapies Announces First Patient Treated In The Rebalance-HF IDE Feasibility Trial

Successful use of the Satera™ Ablation System aims to improve chronic heart failure NEW YORK, March 1, 2021 /PRNewswire/ — Axon Therapies, a Coridea portfolio company focused on addressing a root cause of heart failure, today announced the treatment of the first patient in the randomized, controlled REBALANCE-HF IDE feasibility trial. The trial […]

Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc.

CHICAGO, March 1, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021. On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published new Category 1 reimbursement rates applicable to the Current Procedural Terminology (CPT) codes for the […]

Biobeat Wearable Patient Monitoring Devices Tested In Acute Ischemic Stroke Patient Clinical Study

Pilot Study Aims to Assess Feasibility and Effectiveness of Monitoring Acute Cerebrovascular Accident Patients with Non-Invasive Continuous Monitoring Devices PETAH TIKVA, Israel, March 1, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, has announced a collaborative pilot study with Nuvance Health’s Vassar Brothers Medical Center […]

iRhythm Technologies, Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc.

RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive […]

PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association (AdvaMed), the world’s leading medical technology trade association, has appointed Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive […]

DHR Health and Cipherome to Pioneer Personalized Medicine Project in Patients Undergoing Percutaneous Coronary Interventions

The First Gene Based Project to be conducted in the Texas Rio Grande Valley EDINBURG, Texas–(BUSINESS WIRE)–Can a medical tool predict the risk of certain medications based on a patient’s genetics, and, if so, could this information lead to doctors customizing a patient’s drug therapy? The tool being studied at […]

Epsilon Imaging Partners With Siemens Healthineers to Offer Echoinsight® Visualization and Analysis Strain Imaging to syngo® Dynamics Users

EchoInsight® Strain imaging Standardizes Analysis and Interpretation, while Improving Diagnostic Assessment and Optimizing Care Through Better Patient Monitoring ANN ARBOR, Mich.–(BUSINESS WIRE)–Epsilon Imaging, a visualization and analysis software provider transforming cardiac diagnostic workflow with strain imaging, today announced a partnership with Siemens Healthineers, a leading developer of medical imaging and information […]

Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease

Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group, Casdin Capital and GV. Funds will help advance lead gene therapy program in hypertrophic […]